HK1159010A1 - Disubstituted phthalazine hedgehog pathway antagonists - Google Patents

Disubstituted phthalazine hedgehog pathway antagonists

Info

Publication number
HK1159010A1
HK1159010A1 HK11113436.2A HK11113436A HK1159010A1 HK 1159010 A1 HK1159010 A1 HK 1159010A1 HK 11113436 A HK11113436 A HK 11113436A HK 1159010 A1 HK1159010 A1 HK 1159010A1
Authority
HK
Hong Kong
Prior art keywords
hedgehog pathway
pathway antagonists
disubstituted phthalazine
phthalazine hedgehog
disubstituted
Prior art date
Application number
HK11113436.2A
Other languages
English (en)
Inventor
Jolie Anne Bastian
Philip Arthur Hipskind
Daniel Jon Sall
Takako Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1159010(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1159010A1 publication Critical patent/HK1159010A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK11113436.2A 2008-11-03 2011-12-13 Disubstituted phthalazine hedgehog pathway antagonists HK1159010A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11070308P 2008-11-03 2008-11-03
PCT/US2009/061573 WO2010062507A1 (fr) 2008-11-03 2009-10-22 Antagonistes phtalazine disubstituée de la voie de signalisation hedgehog

Publications (1)

Publication Number Publication Date
HK1159010A1 true HK1159010A1 (en) 2012-07-27

Family

ID=41566219

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113436.2A HK1159010A1 (en) 2008-11-03 2011-12-13 Disubstituted phthalazine hedgehog pathway antagonists

Country Status (30)

Country Link
US (1) US8404687B2 (fr)
EP (1) EP2364185B1 (fr)
JP (1) JP2012507535A (fr)
KR (1) KR101335746B1 (fr)
CN (1) CN102202737B (fr)
AU (1) AU2009320251C1 (fr)
BR (1) BRPI0921437A2 (fr)
CA (1) CA2742539C (fr)
CL (1) CL2011000979A1 (fr)
CO (1) CO6382123A2 (fr)
CR (1) CR20110202A (fr)
CY (1) CY1114023T1 (fr)
DK (1) DK2364185T3 (fr)
EA (1) EA018931B1 (fr)
EC (1) ECSP11011021A (fr)
ES (1) ES2418479T3 (fr)
HK (1) HK1159010A1 (fr)
HR (1) HRP20130527T1 (fr)
IL (1) IL211841A0 (fr)
MA (1) MA32726B1 (fr)
MX (1) MX2011004683A (fr)
NZ (1) NZ591945A (fr)
PE (1) PE20110433A1 (fr)
PL (1) PL2364185T3 (fr)
PT (1) PT2364185E (fr)
SI (1) SI2364185T1 (fr)
TN (1) TN2011000166A1 (fr)
UA (1) UA102115C2 (fr)
WO (1) WO2010062507A1 (fr)
ZA (1) ZA201102448B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5550352B2 (ja) * 2007-03-15 2014-07-16 ノバルティス アーゲー 有機化合物およびその使用
EP2294061A2 (fr) 2008-04-29 2011-03-16 Eli Lilly & Company Antagonistes de la voie de la protéine hedgehog de phtalazine disubstituée
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
PL2358698T3 (pl) 2008-11-17 2013-01-31 Lilly Co Eli Czteropodstawione pirydazyny jako antagoniści szlaku HEDGEHOG
CN102216292B (zh) 2008-11-17 2014-08-13 伊莱利利公司 四取代的哒嗪hedgehog途径拮抗剂
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
US9814703B2 (en) 2013-11-14 2017-11-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of BMP signaling
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
WO2024064245A1 (fr) * 2022-09-23 2024-03-28 Merck Sharp & Dohme Llc Derives de phtalazine utiles en tant qu'inhibiteurs de la proteine receptrice de type nod 3

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
ZA97288B (en) * 1996-01-15 1998-07-14 Janssen Pharmaceutica Nv Angiogenesis inhibiting pyridazinamines
CN1169795C (zh) * 1996-10-01 2004-10-06 协和发酵工业株式会社 环胺取代的含氮杂环化合物及其组合物
AU768130B2 (en) 1998-04-09 2003-12-04 Johns Hopkins University School Of Medicine, The Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
US6432970B2 (en) * 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
AU780358B2 (en) 1999-06-08 2005-03-17 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
WO2003088970A2 (fr) 2002-04-22 2003-10-30 Johns Hopkins University School Of Medicine Modulateurs de voies de signalisation hedgehog, compositions et utilisations associees
AU2003265853A1 (en) 2002-08-29 2004-03-19 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
WO2005033288A2 (fr) * 2003-09-29 2005-04-14 The Johns Hopkins University Antagonistes de la voie hedgehog
TW200533356A (en) 2004-02-24 2005-10-16 Mitsubishi Pharma Corp Fused pyridazine derivatives
AU2005260102A1 (en) 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
SI1789390T1 (sl) * 2004-09-02 2012-05-31 Genentech Inc Piridilni inhibitorji hedgehog signalizacije
EP1900731A1 (fr) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides comme modulateurs du récepteur EP2
JP5550352B2 (ja) 2007-03-15 2014-07-16 ノバルティス アーゲー 有機化合物およびその使用
CA2690378A1 (fr) * 2007-06-25 2008-12-31 Amgen Inc. Composes de phthalazine, compositions et procedes d'utilisation
US8222251B2 (en) 2007-09-07 2012-07-17 Amgen Inc. Pyridopyridazine compounds, compositions and methods of use
EP2294061A2 (fr) * 2008-04-29 2011-03-16 Eli Lilly & Company Antagonistes de la voie de la protéine hedgehog de phtalazine disubstituée
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
PL2358698T3 (pl) 2008-11-17 2013-01-31 Lilly Co Eli Czteropodstawione pirydazyny jako antagoniści szlaku HEDGEHOG
CN102216292B (zh) 2008-11-17 2014-08-13 伊莱利利公司 四取代的哒嗪hedgehog途径拮抗剂
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Also Published As

Publication number Publication date
SI2364185T1 (sl) 2013-07-31
AU2009320251C1 (en) 2013-08-15
NZ591945A (en) 2012-10-26
CA2742539A1 (fr) 2010-06-03
CN102202737A (zh) 2011-09-28
DK2364185T3 (da) 2013-06-03
JP2012507535A (ja) 2012-03-29
PE20110433A1 (es) 2011-07-09
CY1114023T1 (el) 2016-07-27
CR20110202A (es) 2011-06-09
AU2009320251B2 (en) 2013-01-24
CA2742539C (fr) 2014-05-06
PL2364185T3 (pl) 2013-10-31
EA201170640A1 (ru) 2011-12-30
EP2364185B1 (fr) 2013-05-22
EA018931B1 (ru) 2013-11-29
US8404687B2 (en) 2013-03-26
UA102115C2 (ru) 2013-06-10
KR20110066212A (ko) 2011-06-16
CO6382123A2 (es) 2012-02-15
BRPI0921437A2 (pt) 2018-10-30
CN102202737B (zh) 2014-03-26
MA32726B1 (fr) 2011-10-02
CL2011000979A1 (es) 2011-10-07
US20110190304A1 (en) 2011-08-04
ES2418479T3 (es) 2013-08-14
AU2009320251A1 (en) 2010-06-03
ZA201102448B (en) 2012-09-26
IL211841A0 (en) 2011-06-30
EP2364185A1 (fr) 2011-09-14
ECSP11011021A (es) 2011-06-30
MX2011004683A (es) 2011-06-20
PT2364185E (pt) 2013-07-24
KR101335746B1 (ko) 2013-12-12
WO2010062507A1 (fr) 2010-06-03
HRP20130527T1 (en) 2013-07-31
TN2011000166A1 (en) 2012-12-17

Similar Documents

Publication Publication Date Title
HRP20130408T1 (en) Disubstituted phthalazine hedgehog pathway antagonists
IL208211A0 (en) Disubstituted phthalazine hedgehog pathway antagonists
HRP20130527T1 (en) Disubstituted phthalazine hedgehog pathway antagonists
IL237392B (en) Pharmaceutical combination
EP2361340A4 (fr) Garniture d'étanchéité
IL207378A0 (en) Pharmaceutical solid state forms
DK2301489T3 (en) Tredimensionelt ortopædisk udstyr til rygsøjlen
HK1152640A1 (en) Pharmaceutical combination
HUP0800591A2 (en) Stable pharmaceutical combination
AU322206S (en) Monitor
HU0800414D0 (en) Pharmaceutical combination
GB0812816D0 (en) Therapeutic substances
GB0818712D0 (en) Therapeutic substances
GB0810952D0 (en) Therapeutic substances
GB0804377D0 (en) Therapeutic substances
GB0802576D0 (en) Dosage form
AU2008298V (en) Proquest D3 Dianella caerulea
GB0807453D0 (en) General problem solver
HU3495U (en) Construction set
GB0819442D0 (en) Monitor
GB0805729D0 (en) K9 easybath

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161022